Literature DB >> 7896978

Psychiatric comorbidity, health status, and functional impairment associated with alcohol abuse and dependence in primary care patients: findings of the PRIME MD-1000 study.

J G Johnson1, R L Spitzer, J B Williams, K Kroenke, M Linzer, D Brody, F deGruy, S Hahn.   

Abstract

The psychiatric comorbidity, health, and functioning of primary care patients with alcohol abuse and dependence (AAD) were investigated in a sample of 1,000 patients. Psychiatric symptomatology was assessed with the Primary Care Evaluation of Mental Disorders (PRIME-MD) diagnostic system. Health and functional status was assessed with the Medical Outcomes Study Short Form General Health Survey (SF-20). Results indicated that use of the PRIME-MD system brought about a 71% increase in physician recognition of AAD. AAD patients were diagnosed with substantial psychiatric comorbidity, and they reported poorer health and functioning than did patients without any psychiatric disorders. However, they reported less impairment and psychiatric comorbidity than did patients with other psychiatric disorders. Results also indicated that AAD patients' health and functioning were associated with the presence or absence of psychiatric comorbidity.

Entities:  

Mesh:

Year:  1995        PMID: 7896978     DOI: 10.1037//0022-006x.63.1.133

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  16 in total

1.  The covariation of multiple risk factors in primary care: a latent class analysis.

Authors:  Jennifer S Funderburk; Stephen A Maisto; Dawn E Sugarman; Mike Wade
Journal:  J Behav Med       Date:  2008-09-18

2.  Behavioral Health Assessments and Interventions of Psychology Trainees and Residents During Dual Interviewing: Replication and Extension.

Authors:  John H Porcerelli; John R Jones; Jillian E Grabowski; William Murdoch
Journal:  J Clin Psychol Med Settings       Date:  2019-06

3.  Training primary care clinicians in maintenance care for moderated alcohol use.

Authors:  Peter D Friedmann; Jennifer Rose; Jumi Hayaki; Susan Ramsey; Anthony Charuvastra; Catherine Dubé; Debra Herman; Michael D Stein
Journal:  J Gen Intern Med       Date:  2006-09-11       Impact factor: 5.128

4.  Don't wanna go through that madness no more: quality of life satisfaction as predictor of sustained remission from illicit drug misuse.

Authors:  Alexandre B Laudet; Jeffrey B Becker; William L White
Journal:  Subst Use Misuse       Date:  2009       Impact factor: 2.164

5.  Mental health treatment received by primary care patients with posttraumatic stress disorder.

Authors:  Benjamin F Rodriguez; Risa B Weisberg; Maria E Pagano; Jason T Machan; Larry Culpepper; Martin B Keller
Journal:  J Clin Psychiatry       Date:  2003-10       Impact factor: 4.384

6.  Effect of extended-release naltrexone (XR-NTX) on quality of life in alcohol-dependent patients.

Authors:  Helen M Pettinati; David R Gastfriend; Qunming Dong; Henry R Kranzler; Stephanie S O'Malley
Journal:  Alcohol Clin Exp Res       Date:  2008-11-25       Impact factor: 3.455

7.  Patient follow-up in primary care after behavioral health screening in an urban public hospital system: a prospective, observational study of 2686 patients.

Authors:  Megan R Gerber; Howard J Cabral; Shakira Franco Suglia; Robert C Joseph; Lise E Fried
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

8.  Transitions in and out of alcohol use disorders: their associations with conditional changes in quality of life over a 3-year follow-up interval.

Authors:  Deborah A Dawson; Ting-Kai Li; S Patricia Chou; Bridget F Grant
Journal:  Alcohol Alcohol       Date:  2008-11-28       Impact factor: 2.826

9.  Determinants of improvement in quality of life of alcohol-dependent patients during an inpatient withdrawal programme.

Authors:  Pierre Lahmek; Ivan Berlin; Laurent Michel; Chafia Berghout; Nadine Meunier; Henri-Jean Aubin
Journal:  Int J Med Sci       Date:  2009-05-18       Impact factor: 3.738

10.  Primary care, public health, and mental health.

Authors:  Benjamin G Druss; Robert A Mays; Valerie J Edwards; Daniel P Chapman
Journal:  Prev Chronic Dis       Date:  2009-12-15       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.